NYSE American

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Representative image of oilfield pumpjacks and storage tanks in the Anadarko Basin, reflecting ConocoPhillips’ asset divestiture strategy.

Phoenix Energy launches $75m preferred share IPO while posting record Q2 earnings and operational milestones

Phoenix Energy launches $75M preferred share IPO and posts record Q2 results with strong drilling milestones. Find out why investors are watching closely.

byPallavi Madhiraju

August 29, 2025

Honda Aircraft abruptly terminates major fleet deal with Volato, raising concerns over future operations

Honda Aircraft Company has taken the drastic step of terminating its Fleet Purchase Agreement with Volato Group, Inc.,…

byPallavi Madhiraju

September 14, 2024

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Phoenix Energy launches $75m preferred share IPO while posting record Q2 earnings and operational milestones

Honda Aircraft abruptly terminates major fleet deal with Volato, raising concerns over future operations

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

SAMILBIO expands Chaeyun skincare with two November launches as K-beauty exports reach $11.1bn

Schneider Electric Infrastructure (SCHNEIDER) shares fall 3.5% despite new factory expansion: What will November results reveal?

Haleon (HLN) near 319p: Does a 15% share-price crash make its valuation attractive after the growth downgrade?

Ethan Allen will split CEO and chair roles, but who gets to choose Farooq Kathwari’s successor?